When it comes to smart drugs and nootropics, there’s a lot of information out there. Unfortunately, there’s a lot of misinformation out there as well. It’s a topic best covered by reporters and editors who have spent years developing expert sources in the field and who have a proven track record of producing solid, fact-based stories that contribute to the public’s knowledge of the subject.
NewsXPartners, a media organization with a diverse base of clients and content providers, has been providing the public with some of the most reliable and up-to-date information about this topic for more than 15 years. The group’s expertise and knowledge base have recently been recognized by Smart Drugs and Supplements, which awarded NXP its first-ever Best PR Agency Award.
Smart Drugs, Supplements, and Complex PR: NewsXPartners Treads Boldly but Intelligently is an original (SmartDrugs&Supplements) article.
Smart Drugs and Supplements is a digital magazine that provides continuously updated content on smart drugs and nootropics, as well as dietary supplements, vitamins, minerals, and herbals.
“We provide a tremendous amount of content in this area, unlike any other PR firm on the topic of nootropics,” states NXP’s Editor-In-Chief, who regularly works with reporters and other editors covering this field.
“It’s a quantifiable fact that we have produced more output on nootropics and smart drugs than any other PR or publicity firm. We’ve contributed more to the topic, which means we have added value to the knowledge base.”
Going above and beyond the usual work of PR firms is part of the NXP heritage. Established in 2006 as an informal behind-the-scenes association of independent writers, reporters, journalists, publicists, and public relations professionals, the organization began to promote the reputation and branding of select clients. During that time, the principal media resources were traditional print newspapers and magazines.
NXP has now expanded its operations and is actively engaged in all forms of e-media, including digital publications, blogs, and podcasts. It has also divided its workload into several independent areas of content creation, marketing, and distribution. Its Publicity and Public Relations Group serves its clients’ needs with discretion and complete confidentiality in respect of those clients. The objective is to put clients at the media forefront without revealing their involvement in any paid media campaigns.
Unlike many advertising agencies and publicity firms, NXP never competes with its clients for public attention. As a matter of policy, NXP does not engage in its own name on social media platforms, such as Facebook, Instagram, TikTok, Twitter, LinkedIn, and the like.
One of the founding principles of NXP is the belief that commercial interests and excellent writers can coexist harmoniously within the same ecosystem. NXP also believes that news and infomedia content creators and providers can work comfortably with commercial interests to enhance each other’s reach, influence, and profitability.
In the field of nootropics and smart drugs, it was only natural that NXP became a leading source of information because of its clients who were already in the supplement business. This helped the writers, who had already developed reliable sources in the nutrition field, and it also supported the editors who were providing stories for publications that specialized in the same field.
NXP’s Editor-In-Chief affirms that the expertise developed by the company has allowed them to provide a great deal of content about the science behind smart drugs and nootropics, describing the domain as “a place where lots of public relations firms don’t dare to go.”
By contrast, NXP’s reporters produce fact-based stories, relying on reputable sources provided by the companies that hire NXP to get their messages to the public. This approach gives these stories a level of credibility that sets them apart from the usual public relations fodder.
“It’s because of our client base,” NXP’s Editor-In-Chief asserts. “They understand the actual science where others don’t.”
The latest award from Smart Drugs and Supplements is attributed to the consistent credibility of the editorial content provided by the NXP team of writers and editors.
“SDAS has a very specific target market and audience,” NXP’s Editor-In-Chief explains. “They are very interested in what we are reporting about.”
Over-the-counter supplements that are touted to enhance cognitive function and memory and eliminate brain fog are part of a rapidly growing market. Many of the stories produced by NXP are designed to help readers sort through these claims and find products that are backed by reliable scientific research and clinical trials.
The global nootropics and smart drugs market is expected to grow from $3.36 billion in 2021 to $3.95 billion in 2022 at a compound annual growth rate of 17.5 percent. This market includes the sales of nootropic solutions and services provided by entities that help boost brain performance. Nootropics and smart drugs refer to memory-enhancing substances which have a stimulating effect.
The increasing expenditure on health and wellness is expected to propel the growth of the nootropics and smart drugs market. These products are useful in maintaining an individual’s health and wellness, so they are expected to benefit from the overall growth of that marketplace as well.
The adoption of vegan nootropics and smart drugs is gaining popularity in the global market, and many of the reports generated by NXP focus on this important segment of the business. Major companies operating in the nootropics and smart drugs market are turning to new organic product innovations to meet consumer demand and maintain their market position.
In addition to consumers who are looking to improve their overall health, NXP’s Editor-In-Chief notes an increasing number of people who are looking for ways to use over-the-counter nootropics and smart drugs to push their mental capacity even further. Instead of just trying to keep up with their contemporaries and fight off the effects of aging, these customers trade information and stay on top of cutting-edge developments in smart drug research.
“We have a small but growing market of bio-hackers and neuro-hackers—the second group is like bodybuilders for the mind,” says NXP’s Editor-In-Chief. “They are a very particular bunch. They are trying to transcend what they were given by nature at birth.”
While that group remains in the minority, NXP works to cater to their needs by providing the same quality journalism it has become known for. Moreover, NXP is pushing beyond simply reporting stories and delving into the field of helping companies reach new audiences they might not even have been aware of.
NXP believes that editorial promotion, publicity, and public relations are the most powerful tools for increasing industry and professional revenue and for elevating the visibility of thought leaders. The organization takes up where traditional advertising leaves off, and its unique business model provides benefits for all parties involved in the process. Growth need not be a zero-sum game; all participants can win.
New clients come to NXP directly from its current members and through satisfied and enthusiastic referrals. NXP does not promote itself through traditional media, e-media, or social media channels. Writers, editors, and marketing specialists work confidentially with clients to ensure them the spotlight, and the organization gladly takes a backseat when clients are taking their bows.
NXP’s Editor-In-Chief affirms that this model has worked well for the company’s clients, and their satisfaction can be seen in the feedback they give NXP once their publicity campaign is complete.
“We are listening to our clients as well as listening to the marketplace,” NXP’s Editor-In-Chief says.
Unlike the giant advertising companies and PR firms of yesteryear, NXP does not compete with its clients for attention in the media—clients and their confidentiality are governing priorities. As a matter of professionalism and policy, NXP does not announce client engagements, and as far as the general public is concerned, those clients are always speaking for themselves.
About
Smart Drugs And Supplements is a digital publication featuring news and information about nootropics.
Important Note: The information contained in this article is for general informational purposes only, and should not be construed as health or medical advice, nor is it intended to diagnose, prevent, treat, or cure any disease or health condition. Before embarking on any diet, fitness regimen, or program of nutritional supplementation, it is advisable to consult your healthcare professional in order to determine its safety and probable efficacy in terms of your individual state of health.
Regarding Nutritional Supplements Or Other Non-Prescription Health Products: If any nutritional supplements or other non-prescription health products are mentioned in the foregoing article, any claims or statements made about them have not been evaluated by the U.S. Food and Drug Administration, and such nutritional supplements or other health products are not intended to diagnose, treat, cure, or prevent any disease.
